CDMO Avid Bioservices, Inc Earnings per share for the last twelve months

Avid Bioservices, Inc. (CDMO) relies heavily on external reagent suppliers while implementing automation to eliminate biosynthesis errors. The annual net income per share illustrates the long-term business trend, where -2.40 represents the current metric level. Stability is ensured by long-term contracts for the production of biologics at the company's own high-tech plants in California.
Summary analytical data breakdowns for Avid Bioservices, Inc. (CDMO)

Avid Bioservices, Inc. (CDMO) is scaling its biologic production capacities for the global pharmaceutical market. The rolling year earnings per share trend reflects the efficiency of this expansion. This metric is calculated as the ratio of net profit to the total number of securities, excluding the impact of issuance. The growth of this indicator confirms the successful ramp-up of plants to design capacity and increasing margins. This positive trend signals the business's ability to convert capital expenditures into real shareholder returns.